Library/For Long/Vesugen

RUO · Research Use Only⚠ Russian-only data✓ Free to read

Vesugen

Three amino acids out of a Russian lab, sold for blood-vessel health, with almost no real proof behind it.

Updated 03 May 2026Read 3 minBacked by 27 studies

The quick version

What it is: A 3-piece peptide (Lys-Glu-Asp) from the Khavinson 'bioregulator' family
Is it FDA-approved?: No. Sold 'for research only'
How strong is the proof?: Very weak. One lab, mostly Russian-language, no independent repeat
How you take it: A shot under the skin, in short cycles
Typical result: Claimed vascular benefit, but nothing you could measure in a short cycle
Biggest catch: All the evidence comes from a single lab. Buying it is buying a guess

Any word with a dotted underline is a science word — tap it for a plain-English meaning.

In plain words.

Vesugen is a very small , just 3 building blocks (lysine, glutamate, aspartate).

It comes from the "short bioregulator" family created by a Russian researcher named Khavinson. It is sold for blood-vessel and circulation health.

It is not . It is sold "for research only."

It has the same evidence pattern as its cousin Epitalon: one lab, decades of work, mostly Russian-language papers, and no independent group confirming it.

What people use it for.

People use it for "vascular" and circulation health, hoping it helps blood-vessel lining and aging.

Longevity hobbyists run it in short cycles, often paired with Epitalon and other Khavinson peptides.

It is not for weight, recovery, or muscle. The claims are all about blood vessels.

Does it actually work?

There is almost no good proof. The English-language literature is nearly empty.

The Khavinson group reports benefits, but no independent lab has repeated the work. There are no Western Phase 2 or 3 trials.

The popular " Vesugen with Epitalon" idea does not add up either. Both come from the same lab. Adding a second unproven does not double the data. It just doubles the bet on one unconfirmed source.

what you’ve probably heard.

The claims floating around online, and how true they actually are.

“Vesugen protects your blood vessels and slows vascular aging.”

unproven

The vascular pitch comes from a single source: the Khavinson group in Russia. No independent lab has repeated the work, the English-language record is nearly empty, and there are no Western Phase 2 or 3 trials to point to.

“Running Epitalon alongside it doubles your anti-aging payoff.”

myth

Both come from the same lab. Adding a second unproven does not double the data. It just doubles the bet on one source that nobody outside has confirmed.

“It is just three amino acids, so it is harmless.”

half true

There are no big safety alarms, but there is also very little long-term data, all from one lab. The one real catch is blood pressure: the same papers describe it letting patients cut their BP medicine, so stacked on a BP drug the combined drop can go too far.

“You will feel the vascular benefit after a cycle or two.”

The usual is 10 to 20 days. That is far too brief to shift a cholesterol panel, a heart scan, or any real blood-vessel measure. Even if you run it, you have no honest way to tell whether it did anything.

How you take it.

People run it in short cycles, usually 5-10 mg a day for 10-20 days, two or three times a year.

It comes as a freeze-dried () powder you mix with ().

Be honest about what a short can show. A 10-20 day pulse is far too brief to shift a cholesterol panel, a heart scan, or any real blood-vessel measure. If you run it, the most you can honestly do is log your home blood pressure for two weeks before and two weeks after, and see whether the reading budges at all.

What to watch out for.

There are no big safety alarms, but there is also very little long-term safety data, all from one lab.

The main real-world risk is with blood pressure. The Khavinson group describes Vesugen as something that let patients use lower doses of blood pressure drugs. That means the effects can add up. If you are on a blood pressure medicine, the combined drop could be too much.

If you take any heart or blood pressure medication, do not run this without your doctor watching your home readings. Talk to a real doctor. We are not your doctor.

Where people get it.

From safest to riskiest.

Brand. None. There is no Vesugen.
. A few pharmacies carry it, about $100-$220 a month. Mid-to-high risk, since the only evidence is from one lab.
Research-only (). The main supply. Sold "for research only," about $30-$120 a month. Cheap, because such a tiny is easy to make.
. Overseas raw. Demand is low, so supply comes and goes.

There is no strong scam pattern here, mostly because barely anyone is buying it.

Our honest take.

You would be running the experiment yourself, and the only lab that has ever studied this is the one selling the idea. Vesugen is three amino acids sold for blood-vessel health on the strength of one Russian group's work that no outside lab has ever repeated.

A 10-20 day cannot move a cholesterol panel or a heart scan, so even if you run it, you will have no way to tell whether it did anything.

If you try it anyway, the one real-world catch is blood pressure. The same papers describe it letting patients cut their BP medicine, so stacked on a blood pressure drug the combined drop can go too far. Never run it without your doctor watching your home readings.

The studies behind this.

We read the research so you don't have to. Here's where the facts on this page come from.

Learn about these too.

We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.

Keep up with this stuff

Want the rest of the peptide world, in plain English?

New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.